Background illustration for clinical trials search

Paid Clinical Trials Fullerton

Discover 3,591 paid clinical trials in Fullerton, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

for
Immune Thrombocytopenia
Location: Los Angeles CA, Clovis CA, Ogden UT, Portland OR,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07007962

Phase 3, Recruiting

Visible Abdominal Distension

for
Irritable Bowel Syndrome, Dyspepsia, Functional Bloating
Location: Los Angeles CA, Hamilton
Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Sex: All

Age: 18 - 70+

Code: NCT06369753

Recruiting

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-Resistant Prostate Cancer
Location: Los Angeles CA, Goodyear AZ, Scottsdale AZ,
Sponsor: Kyntra Bio

Sex: Male

Age: 18+

Code: NCT06842498

Phase 2, Recruiting

A Study of KK2269 in Adult Participants With Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Newport Beach CA, Duarte CA, Scottsdale AZ, Seattle WA,
Sponsor: Kyowa Kirin Co., Ltd.

Sex: All

Age: 18+

Code: NCT06266299

Phase 1, Recruiting

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

for
Multiple Myeloma
Location: Irvine CA, Miami FL
Sponsor: Hoag Memorial Hospital Presbyterian

Sex: All

Age: 21+

Code: NCT04814615

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)

for
Internal Hemorrhoids, HAE
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 70+

Code: NCT07179601

Recruiting

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Pasadena CA, La Jolla CA, Stanford CA, San Francisco CA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07207811

Phase 3, Recruiting

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease

for
Immunoglobulin G4 Related Disease
Location: Fontana CA, San Jose CA, Sacramento CA, Seattle WA,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07190196

Phase 3, Recruiting

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

for
Prostate Carcinoma, Recurrent Prostate Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Male

Age: 30 - 70+

Code: NCT07202247

Phase 2, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: La Palma CA, Long Beach CA, Newport Beach CA,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase 3, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Long Beach CA, Los Angeles CA, Northridge CA,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190222

Phase 3, Recruiting

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

for
Leukemia, Myeloid, Acute, Myelodysplastic Syndromes,
Location: Los Angeles CA, Portland OR, Nashville TN, Tampa FL,
Sponsor: Orca Biosystems, Inc.

Sex: All

Age: 18+

Code: NCT07216443

Phase 2, Recruiting

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Los Angeles CA, Stanford CA, San Francisco CA,
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06947928

Phase 2, Phase 3, Recruiting

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

for
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion,
Location: Newport Beach CA, Torrance CA, Los Angeles CA,
Sponsor: Bayer

Sex: All

Age: 0+

Code: NCT04142437

Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

for
Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer,
Location: Los Angeles CA, La Jolla CA, Houston TX, Minneapolis MN,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT07216105

Phase 1, Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Newport Beach CA, Los Angeles CA, Clovis CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase 1, Phase 2, Recruiting

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Los Angeles CA, Fayetteville AR, Houston TX,
Sponsor: AstraZeneca

Sex: Male

Age: 18 - 70+

Code: NCT07181161

Phase 1, Phase 2, Recruiting

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

for
Urothelial Cancer, Bladder Cancer
Location: Los Angeles CA, Dallas TX, Peoria IL, Niles IL,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07129993

Phase 2, Phase 3, Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: Duarte CA, Los Angeles CA, San Francisco CA, Houston TX,
Sponsor: EvolveImmune United, Inc

Sex: All

Age: 18+

Code: NCT07217171

Phase 1, Recruiting

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

for
HIV
Location: Los Angeles CA, Providence RI
Sponsor: Westat

Sex: All

Age: 16 - 24

Code: NCT06444360

Recruiting